Arcturus Therapeutics (ARCT) PT Lowered to $20 at Wells Fargo
Tweet
Share
E-mailGet Alerts ARCT Hot Sheet
Price: $7.60 -0.65%
Rating Summary:
12 Buy, 5 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
12 Buy, 5 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Wells Fargo analyst Yanan Zhu lowered the price target on Arcturus Therapeutics (NASDAQ: ARCT) to $20.00 (from $42.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Old Dominion Freight Line (ODFL) PT Raised to $233 at TD Cowen
- Nomura/Instinet Downgrades T&D Holdings Inc (8795:JP) (TDHOY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
